Euroscreen 

Euroscreen S.A.

Euroscreen S.A.
There are no Items to display

Latest News

NEWS - Euroscreen starts in parallel two Phase 2 clinical trials with ESN364 in UF and PCOS patients

NEWS - Euroscreen receives 3.86 million Grant for GPCR Neurodegenerative Diseases Drug Development

NEWS - Euroscreen Announces Positive Completion of Phase I Trial of ESN364

Euroscreen FAST

Euroscreen FAST
You are here  :Home